Open access
Aug 2026
Pretreatment TyG-BMI predicts CD19 CAR-T persistence and prognosis in diffuse large B-cell lymphoma
TyG-BMI is an independent prognostic factor in DLBCL that refines IPI-based stratification, and elevated pre-infusion TyG-BMI is associated with attenuated CAR-T cell persistence and inferior outcomes.
Ze-Lin Liu, Rui-Jun Yang, Jia-Wen Chen et al.
· Frontiers in Oncology · 0 citations